Bodily distress syndrome

Bodily distress syndrome DEFAULT

Bodily distress syndrome: A new diagnosis for functional disorders in primary care?

1. Fink P, Rosendal M, Olesen F. Classification of somatization and functional somatic symptoms in primary care. Aust N Z J Psychiatry. 2005;39:772–81. doi: 10.1080/j.1440-1614.2005.01682.x. [PubMed] [CrossRef] [Google Scholar]

2. Fink P, Toft T, Hansen MS, Ornbol E, Olesen F. Symptoms and syndromes of bodily distress: an exploratory study of 978 internal medical, neurological, and primary care patients. Psychosom Med. 2007;69:30–9. doi: 10.1097/PSY.0b013e31802e46eb. [PubMed] [CrossRef] [Google Scholar]

3. Fink P, Rosendal M. Recent developments in the understanding and management of functional somatic symptoms in primary care. Curr Opin Psychiatry. 2008;21:182–8. doi: 10.1097/YCO.0b013e3282f51254. [PubMed] [CrossRef] [Google Scholar]

4. Olde HT, Hassink-Franke L, Dowrick C, Fortes S, Lam C, van der Horst H, et al. Medically unexplained symptoms in family medicine: defining a research agenda. Proceedings from WONCA 2007. Fam Pract. 2008;25:266–71. doi: 10.1093/fampra/cmn041. [PubMed] [CrossRef] [Google Scholar]

5. Creed F, Guthrie E, Fink P, Henningsen P, Rief W, Sharpe M, et al. Is there a better term than “medically unexplained symptoms”? J Psychosom Res. 2010;68:5–8. doi: 10.1016/j.jpsychores.2009.09.004. [PubMed] [CrossRef] [Google Scholar]

6. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. America: Psychiatric Pub Inc; 2013. [Google Scholar]

7. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research. Geneva: WHO;1993.

8. Schroder A, Fink P. Functional somatic syndromes and somatoform disorders in special psychosomatic units: organizational aspects and evidence-based treatment. Psychiatr Clin North Am. 2011;34:673–87. doi: 10.1016/j.psc.2011.05.008. [PubMed] [CrossRef] [Google Scholar]

9. Peveler R, Kilkenny L, Kinmonth AL. Medically unexplained physical symptoms in primary care: a comparison of self-report screening questionnaires and clinical opinion. J Psychosom Res. 1997;42:245–52. doi: 10.1016/S0022-3999(96)00292-9. [PubMed] [CrossRef] [Google Scholar]

10. Stenager EN, Svendsen MA, Stenager E. Disability retirement pension for patients with syndrome diagnoses. A registry study on the basis of data from the social appeal board. Ugeskr Laeger. 2003;165:469–74. [PubMed] [Google Scholar]

11. Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry. 2005;62:903–10. doi: 10.1001/archpsyc.62.8.903. [PubMed] [CrossRef] [Google Scholar]

12. Schroder A, Fink P, Fjordback L, Frostholm L, Rosendal M. Towards a unified treatment approach for functional somatic syndromes and somatization. Ugeskr Laeger. 2010;172:1839–42. [PubMed] [Google Scholar]

13. Simon GE, Gureje O. Stability of somatization disorder and somatization symptoms among primary care patients. Arch Gen Psychiatry. 1999;56(1):90–5. doi: 10.1001/archpsyc.56.1.90. [PubMed] [CrossRef] [Google Scholar]

14. Bermingham SL, Cohen A, Hague J, Parsonage M. The cost of somatisation among the working-age population in England for the year 2008–2009. Ment Health Fam Med. 2010;7:71–84.[PMC free article] [PubMed] [Google Scholar]

15. Barsky AJ, Ettner SL, Horsky J, Bates DW. Resource utilization of patients with hypochondriacal health anxiety and somatization. Med Care. 2001;39:705–15. doi: 10.1097/00005650-200107000-00007. [PubMed] [CrossRef] [Google Scholar]

16. Konnopka A, Schaefert R, Heinrich S, Kaufmann C, Luppa M, Herzog W, et al. Economics of medically unexplained symptoms: a systematic review of the literature. Psychother Psychosom. 2012;81:265–75. doi: 10.1159/000337349. [PubMed] [CrossRef] [Google Scholar]

17. Harris AM, Orav EJ, Bates DW, Barsky AJ. Somatization increases disability independent of comorbidity. J Gen Intern Med. 2009;24:155–61. doi: 10.1007/s11606-008-0845-0.[PMC free article] [PubMed] [CrossRef] [Google Scholar]

18. Werner A, Malterud K. It is hard work behaving as a credible patient: encounters between women with chronic pain and their doctors. Soc Sci Med. 2003;57:1409–19. doi: 10.1016/S0277-9536(02)00520-8. [PubMed] [CrossRef] [Google Scholar]

19. Rosendal M, Bro F, Fink P, Christensen KS, Olesen F. Diagnosis of somatisation: effect of an educational intervention in a cluster randomised controlled trial. Br J Gen Pract. 2003;53:917–22.[PMC free article] [PubMed] [Google Scholar]

20. Schaefert R, Laux G, Kaufmann C, Schellberg D, Bolter R, Szecsenyi J, et al. Diagnosing somatisation disorder (P75) in routine general practice using the international classification of primary care. J Psychosom Res. 2010;69:267–77. doi: 10.1016/j.jpsychores.2010.05.003. [PubMed] [CrossRef] [Google Scholar]

21. Carson AJ, Stone J, Hansen CH, Duncan R, Cavanagh J, Matthews K, et al. Somatic symptom count scores do not identify patients with symptoms unexplained by disease: a prospective cohort study of neurology outpatients. J Neurol Neurosurg Psychiatry. 2015;86:295–301. doi: 10.1136/jnnp-2014-308234. [PubMed] [CrossRef] [Google Scholar]

22. Aaron LA, Burke MM, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med. 2000;160:221–7. doi: 10.1001/archinte.160.2.221. [PubMed] [CrossRef] [Google Scholar]

23. Aaron LA, Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med. 2001;134:868–81. doi: 10.7326/0003-4819-134-9_Part_2-200105011-00011. [PubMed] [CrossRef] [Google Scholar]

24. Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol. 2006;6:26. doi: 10.1186/1471-230X-6-26.[PMC free article] [PubMed] [CrossRef] [Google Scholar]

25. Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet. 2007;369:946–55. doi: 10.1016/S0140-6736(07)60159-7. [PubMed] [CrossRef] [Google Scholar]

26. Kato K, Sullivan PF, Evengard B, Pedersen NL. Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med. 2006;166:1649–54. doi: 10.1001/archinte.166.15.1649. [PubMed] [CrossRef] [Google Scholar]

27. Mayou R, Kirmayer LJ, Simon G, Kroenke K, Sharpe M. Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry. 2005;162:847–55. doi: 10.1176/appi.ajp.162.5.847. [PubMed] [CrossRef] [Google Scholar]

28. Nimnuan C, Rabe-Hesketh S, Wessely S, Hotopf M. How many functional somatic syndromes? J Psychosom Res. 2001;51:549–57. doi: 10.1016/S0022-3999(01)00224-0. [PubMed] [CrossRef] [Google Scholar]

29. Weir PT, Harlan GA, Nkoy FL, Jones SS, Hegmann KT, Gren LH, et al. The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on international classification of diseases, 9th revision codes. J Clin Rheumatol. 2006;12:124–8. doi: 10.1097/01.rhu.0000221817.46231.18. [PubMed] [CrossRef] [Google Scholar]

30. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet. 1999;354:936–9. doi: 10.1016/S0140-6736(98)08320-2. [PubMed] [CrossRef] [Google Scholar]

31. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002;122:1140–56. doi: 10.1053/gast.2002.32392. [PubMed] [CrossRef] [Google Scholar]

32. Swanson LM, Hamilton JC, Feldman MD. Physician-based estimates of medically unexplained symptoms: a comparison of four case definitions. Fam Pract. 2010;27:487–93. doi: 10.1093/fampra/cmq051. [PubMed] [CrossRef] [Google Scholar]

33. Hansen HS, Rosendal M, Oernboel E, Fink P. Are medically unexplained symptoms and functional disorders predictive for the illness course? A two-year follow-up on patients’ health and health care utilisation. J Psychosom Res. 2011;71:38–44. doi: 10.1016/j.jpsychores.2011.02.015. [PubMed] [CrossRef] [Google Scholar]

34. Undeland M, Malterud K. The fibromyalgia diagnosis: hardly helpful for the patients? A qualitative focus group study. Scand J Prim Health Care. 2007;25:250–5. doi: 10.1080/02813430701706568.[PMC free article] [PubMed] [CrossRef] [Google Scholar]

35. Frances A. The new somatic symptom disorder in DSM-5 risks mislabeling many people as mentally ill. BMJ. 2013;346:f1580. doi: 10.1136/bmj.f1580. [PubMed] [CrossRef] [Google Scholar]

36. Hauser W, Wolfe F. The Somatic Symptom Disorder in DSM 5 risks mislabelling people with major medical diseases as mentally ill. J Psychosom Res. 2013;75:586–7. doi: 10.1016/j.jpsychores.2013.09.005. [PubMed] [CrossRef] [Google Scholar]

37. Wolfe F, Walitt BT, Katz RS, Hauser W. Symptoms, the nature of fibromyalgia, and diagnostic and statistical manual 5 (DSM-5) defined mental illness in patients with rheumatoid arthritis and fibromyalgia. PLoS One. 2014;9 doi: 10.1371/journal.pone.0088740.[PMC free article] [PubMed] [CrossRef] [Google Scholar]

38. Burton C. Can we explain medically unexplained symptoms? Fam Pract. 2014;31:623–4. doi: 10.1093/fampra/cmu067. [PubMed] [CrossRef] [Google Scholar]

39. Price J, Leaver L. ABC of psychological medicine: beginning treatment. BMJ. 2002;325:33–5. doi: 10.1136/bmj.325.7354.33.[PMC free article] [PubMed] [CrossRef] [Google Scholar]

40. Fink P, Schroder A. One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. J Psychosom Res. 2010;68:415–26. doi: 10.1016/j.jpsychores.2010.02.004. [PubMed] [CrossRef] [Google Scholar]

41. Budtz-Lilly A, Vestergaard M, Fink P, Carlsen AH, Rosendal M. Patient characteristics and frequency of bodily distress syndrome in primary care: a cross-sectional study. Br J Gen Pract 2015 Sep;65(638):e617-e623. [PMC free article] [PubMed]

42. Budtz-Lilly A, Vestergaard M, Fink P, Carlsen AH, Rosendal M. The prognosis of bodily distress syndrome: a cohort study in primary care. Gen Hosp Psychiatry 2015 Nov;37(6):560-6. [PubMed]

43. Budtz-Lilly A, Fink P, Ornbol E, Vestergaard M, Moth G, Christensen KS, et al. A new questionnaire to identify bodily distress in primary care: the ‘BDS checklist’ J Psychosom Res. 2015;78:536–45. doi: 10.1016/j.jpsychores.2015.03.006. [PubMed] [CrossRef] [Google Scholar]

44. Mette Trøllund Rask, Eva Ørnbøl, Marianne Rosendal, Per Fink: Long-term outcome of bodily distress syndrome in primary care: a follow-up study on healthcare costs, work disability, and self-rated health. Submitted. [PMC free article] [PubMed]

45. Fjorback LO, Arendt M, Ornbol E, Walach H, Rehfeld E, Schroder A, et al. Mindfulness therapy for somatization disorder and functional somatic syndromes: randomized trial with one-year follow-up. J Psychosom Res. 2013;74:31–40. doi: 10.1016/j.jpsychores.2012.09.006. [PubMed] [CrossRef] [Google Scholar]

46. Schroder A, Rehfeld E, Ornbol E, Sharpe M, Licht RW, Fink P. Cognitive-behavioural group treatment for a range of functional somatic syndromes: randomised trial. Br J Psychiatry. 2012;200:499–507. doi: 10.1192/bjp.bp.111.098681. [PubMed] [CrossRef] [Google Scholar]

47. Rief W, Isaac M. The future of somatoform disorders: somatic symptom disorder, bodily distress disorder or functional syndromes? Curr Opin Psychiatry. 2014;27:315–9. doi: 10.1097/YCO.0000000000000089. [PubMed] [CrossRef] [Google Scholar]

48. Kato K, Sullivan PF, Evengard B, Pedersen NL. A population-based twin study of functional somatic syndromes. Psychol Med. 2009;39:497–505. doi: 10.1017/S0033291708003784.[PMC free article] [PubMed] [CrossRef] [Google Scholar]

49. Kato K, Sullivan PF, Pedersen NL. Latent class analysis of functional somatic symptoms in a population-based sample of twins. J Psychosom Res. 2010;68:447–53. doi: 10.1016/j.jpsychores.2010.01.010.[PMC free article] [PubMed] [CrossRef] [Google Scholar]

50. Witthoft M, Hiller W, Loch N, Jasper F. The latent structure of medically unexplained symptoms and its relation to functional somatic syndromes. Int J Behav Med. 2013;20:172–83. doi: 10.1007/s12529-012-9237-2. [PubMed] [CrossRef] [Google Scholar]

51. Simon G, Gater R, Kisely S, Piccinelli M. Somatic symptoms of distress: an international primary care study. Psychosom Med. 1996;58:481–8. doi: 10.1097/00006842-199609000-00010. [PubMed] [CrossRef] [Google Scholar]

52. Rief W, Pilger F, Ihle D, Verkerk R, Scharpe S, Maes M. Psychobiological aspects of somatoform disorders: contributions of monoaminergic transmitter systems. Neuropsychobiology. 2004;49:24–9. doi: 10.1159/000075335. [PubMed] [CrossRef] [Google Scholar]

53. Creed F, Barsky A, Leiknes KA. Epidemiology: prevalence, causes and consequences. I: Creed F, Henningsen P, Fink P, eds. Medically Unexplained Symptoms, Somatisation and Bodily Distress. First. udg. Cambridge: Cambridge University Press; 2011. pp. 1–42. [Google Scholar]

54. Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med. 2003;65:528–33. doi: 10.1097/01.PSY.0000075977.90337.E7. [PubMed] [CrossRef] [Google Scholar]

55. Gara MA, Silver RC, Escobar JI, Holman A, Waitzkin H. A hierarchical classes analysis (HICLAS) of primary care patients with medically unexplained somatic symptoms. Psychiatry Res. 1998;81:77–86. doi: 10.1016/S0165-1781(98)00088-2. [PubMed] [CrossRef] [Google Scholar]

56. Liu G, Clark MR, Eaton WW. Structural factor analyses for medically unexplained somatic symptoms of somatization disorder in the epidemiologic catchment area study. Psychol Med. 1997;27:617–26. doi: 10.1017/S0033291797004844. [PubMed] [CrossRef] [Google Scholar]

57. Robbins JM, Kirmayer LJ, Hemami S. Latent variable models of functional somatic distress. J Nerv Ment Dis. 1997;185:606–15. doi: 10.1097/00005053-199710000-00003. [PubMed] [CrossRef] [Google Scholar]

58. Rosmalen JG, Tak LM, de JP. Empirical foundations for the diagnosis of somatization: implications for DSM-5. Psychol Med. 2011;41:1133–42. doi: 10.1017/S0033291710001625. [PubMed] [CrossRef] [Google Scholar]

59. Schroder A, Fink P. The proposed diagnosis of somatic symptom disorders in DSM-V: two steps forward and one step backward? J Psychosom Res. 2010;68:95–6. doi: 10.1016/j.jpsychores.2009.06.013. [PubMed] [CrossRef] [Google Scholar]

60. Deary V, Chalder T, Sharpe M. The cognitive behavioural model of medically unexplained symptoms: a theoretical and empirical review. Clin Psychol Rev. 2007;27:781–97. doi: 10.1016/j.cpr.2007.07.002. [PubMed] [CrossRef] [Google Scholar]

61. Feldman PJ, Cohen S, Doyle WJ, Skoner DP, Gwaltney JM., Jr The impact of personality on the reporting of unfounded symptoms and illness. J Pers Soc Psychol. 1999;77:370–8. doi: 10.1037/0022-3514.77.2.370. [PubMed] [CrossRef] [Google Scholar]

62. Katon W, Sullivan M, Walker E. Medical symptoms without identified pathology: relationship to psychiatric disorders, childhood and adult trauma, and personality traits. Ann Intern Med. 2001;134:917–25. doi: 10.7326/0003-4819-134-9_Part_2-200105011-00017. [PubMed] [CrossRef] [Google Scholar]

63. Martinez-Martinez LA, Mora T, Vargas A, Fuentes-Iniestra M, Martinez-Lavin M. Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case–control studies. J Clin Rheumatol. 2014;20:146–50. [PubMed] [Google Scholar]

64. Fink P, Rosendal M. Funktionelle lidelser - udredgning og behandling. Copenhagen: Munksgaard; 2012. [Google Scholar]

65. Schroder A, Dimsdale JE. Management of somatic symptoms. I: Scientific American Medicine. 2014. [Google Scholar]

66. Bradley LA. Pathophysiologic mechanisms of fibromyalgia and its related disorders. J Clin Psychiatry. 2008;69(Suppl 2):6–13. [PubMed] [Google Scholar]

67. Hamilton WT, Gallagher AM, Thomas JM, White PD. Risk markers for both chronic fatigue and irritable bowel syndromes: a prospective case–control study in primary care. Psychol Med. 2009;39:1913–21. doi: 10.1017/S0033291709005601. [PubMed] [CrossRef] [Google Scholar]

68. Moss-Morris R, Spence M. To “lump” or to “split” the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome? Psychosom Med. 2006;68:463–9. doi: 10.1097/01.psy.0000221384.07521.05. [PubMed] [CrossRef] [Google Scholar]

69. Lowe B, Spitzer RL, Williams JB, Mussell M, Schellberg D, Kroenke K. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiatry. 2008;30:191–9. doi: 10.1016/j.genhosppsych.2008.01.001. [PubMed] [CrossRef] [Google Scholar]

70. Gillespie NA, Zhu G, Heath AC, Hickie IB, Martin NG. The genetic aetiology of somatic distress. Psychol Med. 2000;30:1051–61. doi: 10.1017/S0033291799002640. [PubMed] [CrossRef] [Google Scholar]

71. Lembo AJ, Zaman M, Krueger RF, Tomenson BM, Creed FH. Psychiatric disorder, irritable bowel syndrome, and extra-intestinal symptoms in a population-based sample of twins. Am J Gastroenterol. 2009;104:686–94. doi: 10.1038/ajg.2009.23. [PubMed] [CrossRef] [Google Scholar]

72. Tak LM, Riese H, de Bock GH, Manoharan A, Kok IC, Rosmalen JG. As good as it gets? A meta-analysis and systematic review of methodological quality of heart rate variability studies in functional somatic disorders. Biol Psychol. 2009;82:101–10. doi: 10.1016/j.biopsycho.2009.05.002. [PubMed] [CrossRef] [Google Scholar]

73. Papadopoulos AS, Cleare AJ. Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome. Nat Rev Endocrinol. 2012;8:22–32. doi: 10.1038/nrendo.2011.153. [PubMed] [CrossRef] [Google Scholar]

74. Tak LM, Bakker SJ, Rosmalen JG. Dysfunction of the hypothalamic-pituitary-adrenal axis and functional somatic symptoms: a longitudinal cohort study in the general population. Psychoneuroendocrinology. 2009;34:869–77. doi: 10.1016/j.psyneuen.2008.12.017. [PubMed] [CrossRef] [Google Scholar]

75. Tak LM, Cleare AJ, Ormel J, Manoharan A, Kok IC, Wessely S, et al. Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. Biol Psychol. 2011;87:183–94. doi: 10.1016/j.biopsycho.2011.02.002. [PubMed] [CrossRef] [Google Scholar]

76. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152:S2–15. doi: 10.1016/j.pain.2010.09.030.[PMC free article] [PubMed] [CrossRef] [Google Scholar]

77. Meeus M, Nijs J. Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol. 2007;26:465–73. doi: 10.1007/s10067-006-0433-9.[PMC free article] [PubMed] [CrossRef] [Google Scholar]

78. Dimsdale JE, Dantzer R. A biological substrate for somatoform disorders: importance of pathophysiology. Psychosom Med. 2007;69:850–4. doi: 10.1097/PSY.0b013e31815b00e7.[PMC free article] [PubMed] [CrossRef] [Google Scholar]

79. Schroder A, Fink P, Sharpe M. The management of MUS: Guided by diagnosis or illness severity? Lancet (Psychiatry) 2015. [Google Scholar]

80. Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med. 2007;69:881–8. doi: 10.1097/PSY.0b013e31815b00c4. [PubMed] [CrossRef] [Google Scholar]

81. Burton C. Beyond somatisation: a review of the understanding and treatment of medically unexplained physical symptoms (MUPS) Br J Gen Pract. 2003;53:231–9.[PMC free article] [PubMed] [Google Scholar]

82. Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol. 2014;6:71–80.[PMC free article] [PubMed] [Google Scholar]

83. Lieb R, Zimmermann P, Friis RH, Hofler M, Tholen S, Wittchen HU. The natural course of DSM-IV somatoform disorders and syndromes among adolescents and young adults: a prospective-longitudinal community study. Eur Psychiatry. 2002;17(6):321–31. doi: 10.1016/S0924-9338(02)00686-7. [PubMed] [CrossRef] [Google Scholar]

84. Lam TP, Goldberg DP, Dowell AC, Fortes S, Mbatia JK, Minhas FA, et al. Proposed new diagnoses of anxious depression and bodily stress syndrome in ICD-11-PHC: an international focus group study. Fam Pract. 2013;30:76–87. doi: 10.1093/fampra/cms037. [PubMed] [CrossRef] [Google Scholar]

85. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry. 2003;160:4–12. doi: 10.1176/appi.ajp.160.1.4. [PubMed] [CrossRef] [Google Scholar]

86. Kendell RE. Clinical validity. Psychol Med. 1989;19:45–55. doi: 10.1017/S0033291700011016. [PubMed] [CrossRef] [Google Scholar]

87. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry. 1970;126:983–7. doi: 10.1176/ajp.126.7.983. [PubMed] [CrossRef] [Google Scholar]

88. Henningsen P, Fink P, Hausteiner-Wiehle C, Rief W. Terminology, classification and concepts. I: Creed F, Henningsen P, Fink P, eds. Medically Unexplained Symptoms, Somatisation and Bodily Distress. First. Cambridge: Cambridge University Press; 2011. pp. 43–68. [Google Scholar]

89. First MB, Pincus HA, Levine JB, Williams JB, Ustun B, Peele R. Clinical utility as a criterion for revising psychiatric diagnoses. Am J Psychiatry. 2004;161:946–54. doi: 10.1176/appi.ajp.161.6.946. [PubMed] [CrossRef] [Google Scholar]

90. World Health Organisation . SCAN. Schedules for Clinical Assessment in Neuropsychiatry, version 2.1. Geneva: WHO, Division of Mental Health; 1998. [Google Scholar]

91. Joyce J, Hotopf M, Wessely S. The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review. QJM. 1997;90:223–33. doi: 10.1093/qjmed/90.3.223. [PubMed] [CrossRef] [Google Scholar]

92. Macfarlane GJ, Thomas E, Papageorgiou AC, Schollum J, Croft PR, Silman AJ. The natural history of chronic pain in the community: a better prognosis than in the clinic? J Rheumatol. 1996;23:1617–20. [PubMed] [Google Scholar]

93. Agger J, Schroder A, Fink P, Gormsen L, Jensen TS. Pharmacological treatment of multi-organ bodily distress syndrome: a double-blind, placebo-controlled trial of the effects of imipramine (stress-3) J Psychosom Res. 2013;75:196. doi: 10.1016/j.jpsychores.2013.06.024. [CrossRef] [Google Scholar]

94. Lacourt T, Houtveen J, van Doornen L. “Functional somatic syndromes, one or many?” an answer by cluster analysis. J Psychosom Res. 2013;74:6–11. doi: 10.1016/j.jpsychores.2012.09.013. [PubMed] [CrossRef] [Google Scholar]

95. Edwards MJ, Stone J, Lang AE. From psychogenic movement disorder to functional movement disorder: it’s time to change the name. Mov Disord. 2014;29:849–52. doi: 10.1002/mds.25562. [PubMed] [CrossRef] [Google Scholar]

96. van Ravenzwaaij J, Olde Hartman T, van Ravesteijn H, Eveleigh R, van Rijswijk E, Lucassen P. Explanatory models of medically unexplained symptoms: a qualitative analysis of the literature. Ment Health Fam Med. 2010;7:223–31.[PMC free article] [PubMed]


Bodily distress syndrome (BDS): the evolution from medically unexplained symptoms (MUS)

1. Page LA, Wessely S. Medically unexplained symptoms: exacerbating factors in the doctor–patient encounter. Journal of the Royal Society of Medicine 2003;96:223–7 [PMC free article] [PubMed] [Google Scholar]

2. Bermingham SL, Cohen A, Hague J, et al. The cost of somatisation among the working-age population in England for the year 2008–2009. Mental Health in Family Medicine 2010;7:71–84 [PMC free article] [PubMed] [Google Scholar]

3. Fink P, Hansen MS, Oxhoj ML. The prevalence of somatoform disorders among internal medical patients. Journal of Psychosomatic Research 2004;56:413–18 [PubMed] [Google Scholar]

4. Fink P, Sørensen L, Engberg M, et al. Somatisation in primary care. Prevalence, health care utilization, and general practitioner recognition. Psychosomatics 1999;40:330–38 [PubMed] [Google Scholar]

5. Kroenke K. Symptoms in medical patients: an untended field. American Journal of Medicine 1992;92:3–6S [PubMed] [Google Scholar]

6. Klinkman M, Dowrick C, Fortes S. Mental health classification in primary care. Ivbijaro G. (ed.) Companion to Primary Care Mental Health. Radcliffe Publishing: London, 2012. pp. 166–77 [Google Scholar]

7. Fink P, Toft T, Hansen MS, et al. Symptoms and syndromes of bodily distress: an exploratory study of 978 internal medical, neurological, and primary care patients. Psychosomatic Medicine 2007;69:30–39 [PubMed] [Google Scholar]

8. Fink P, Schröder A. One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. Journal of Psychosomatic Research 2010;68:415–26 [PubMed] [Google Scholar]

9. Goldberg D. A revised mental health classification for use in general medical settings: the ICD-11-PHC. International Psychiatry 2011;8:1–3 [Google Scholar]

10. Goldberg DP, Prisciandaro JJ, Williams P. The primary health care version of ICD-11: the detection of common mental disorders in general medical settings. General Hospital Psychiatry 2012;34:665–70 [PubMed] [Google Scholar]

11. Rasmussen NH, Agerter DC, Bernard ME, et al. Coping styles in primary care adult patients with abridged somatoform disorders. Mental Health in Family Medicine 2010;7:197–207 [PMC free article] [PubMed] [Google Scholar]

12. Van Ravenzwaaij, olde Hartman TC, van Ravesteijn H, et al. Explanatory models of medically unexplained symptoms: a qualitative analysis of the literature. Mental Health in Family Medicine 2010;7:223–31 [PMC free article] [PubMed] [Google Scholar]

13. Edwards TM, Stern A, Clarke DC, et al. The treatment of patients with medically unexplained symptoms in primary care: a review of the literature. Mental Health in Family Medicine 2010;7:209–21 [PMC free article] [PubMed] [Google Scholar]

  1. Michael myers jewelry
  2. Corner farmhouse desk
  3. Calculus 3 triple integrals
  4. Cisco solution architect

Acceptance and Commitment Therapy for Patients With Multi-organ Bodily Distress Syndrome (Stress-4) (Stress-4)

The aim of this study is to test the effect of Acceptance and Commitment Therapy (ACT) in patients with multi-organ Bodily distress syndrome (BDS). BDS is a unifying diagnosis that encompasses a group of closely related conditions such as somatization disorder, fibromyalgia, irritable bowel syndrome and chronic fatigue syndrome. The project consists of a three-armed randomized controlled trial of ACT treatment given as a supplement to standard treatment as either 9-session group therapy or as a 1-day workshop followed by an individual consultation, compared to standard treatment, which is one single advisory consultation.

Primary outcome is patient-rated improvement measured by Clinical Global Improvement Scale (CGI-I). Secondary outcome is functional level (physical, mental and social) measured by the SF-36 Physical Component Summary (PCS). The study includes 180 participants.

Acute Respiratory Distress Syndrome (ARDS)


Syndrome bodily distress


Acute respiratory distress syndrome ( ARDS ) Etiology, Clinical features, Diagnosis, and Treatment


You will also like:


1322 1323 1324 1325 1326